LNCT Transition Dashboards

LOOK AT THIS IF YOU’RE INTERESTED IN:

Understanding Gavi transitioning countries’ progress and challenges around key health and immunization indicators.   

HOW YOU CAN USE THIS MATERIAL:

Compare the performance of your country to other transitioning countries based on key indicators and use that information to learn about approaches that may help improve lower performance areas.   

OVERVIEW:

LNCT’s interactive transition dashboards provide a really helpful overview of transitioning countries’ progress and challenges and also highlight some areas where additional support to countries may be needed. There are a total of three transition dashboards that can be explored:

  1. Country dashboards – provide a detailed breakdown of key transition indicators across the dimensions of coverage, equity, systems, economic performance, and health and immunization financing.
  2. Health & Immunization Financing dashboardshows how LNCT countries compare to each other in terms of economic performance and health financing.
  3. Immunization Performance, Service Delivery, and Supply Data dashboard demonstrates how LNCT countries compare to each other in terms of immunization performance, service delivery and supply.

You May Also Like

Linked Country Case Study: Strengthening Indonesia’s National Immunisation Program

The Linked Immunisation Action Network has supported Indonesia in addressing critical immunisation challenges through peer-to-peer learning and tailored interventions. Amidst COVID-19-related backsliding (DTP3 coverage dropped from 85% in 2019 to 67% in 2021), Indonesia engaged in collaborative learning exchanges to tackle human resource gaps, data system limitations, and subnational inequities. Key initiatives included a study … Read More

Download
File size: 4.54M

Socioeconomic-related inequities in child immunisation: horizontal and vertical dimensions for policy insights

A study in Health Economics Review investigates the economic and equity impacts of expanding immunisation programs in low- and middle-income countries (LMICs), focusing on the cost-effectiveness of introducing new vaccines. The research highlights that while scaling up immunisation efforts requires significant investment, the long-term benefits—such as reduced disease burden, healthcare savings, and improved productivity—justify the … Read More